Zealand Pharma A/S announced the appointment of Eric Rojas as Vice President and Head of Investor Relations, effective April 15, 2026. Eric will report to Henriette Wennicke, Chief Financial Officer, and will be based in Massachusetts, U.S. Eric brings more than two decades of experience in investor relations and finance, having supported both US-listed and European-listed companies across biotech and pharma. He has held senior roles at several companies including Vertex Pharmaceuticals (VRTX), Stoke Therapeutics (STOK), and Shire who were acquired by Takeda for $62 billion.